A phthalide, levistolide A (1), and six coumarins, demethylsuberosin (2), fraxetin (6), and isopraeroside IV (7) were isolated from the methanolic extract of the roots of Angelica tenuissima Nakai. Their chemical structures were confirmed by comparing spectroscopic and reported data. All seven compounds were isolated for the first time from this plant source. The anti-allergic activities of compounds 1-7 were examined using human mast cells, and compounds 1-3 at 10 μM potently suppressed IL-6 expression and inhibited histamine release from human mast cells by more than 30%.
A medicinal plant, Angelica tenuissima Nakai. (=Ligusticum tenuissimum Kitagawa; family Umbelliferae) is a traditional medicine in Asia and is commonly used to treat headaches, diarrhea, epilepsy, and rheumatic arthralgia [1a] . An aqueous extract of A. tenuissima was reported to be anti-inflammatory and to inhibit abdominal pain in mice [1b] . In addition, essential oil from A. tenuissima was found to have antioxidant activity [1c] . Recently, an extract of the plant was reported to have antiviral and osteoclastogenesis inhibitory activities [1d, 1e] . Chemical investigations conducted on extracts of A. tenuissima have reported the presence of phthalides, coumarins, terpenoids, and phenylpropanoids. (Z)-Ligustilide (a phthalide) was identified as a major anti-inflammatory constituent of A. tenuissima extracts [1f, 1g, 1h] . In addition, coumarins have been found to possess broad spectrum biological activities, including anti-cancer, antiinflammatory, and anti-oxidant [1i, 1j] . In a previous study, the coumarins isolated from A. gigas were revealed as antiinflammatory components that inhibited nitric oxide production and suppressed the expressions of iNOS, IL-6, IL-1β, and COX-2 in LPS-stimulated RAW 264.7 cells [1k].
Histamine is a small molecule released from mast cells and functions as a key mediator of allergic inflammation. Over-released histamine can cause severe allergic reactions and immune disorders, and thus, the inhibition of histamine release from mast cells is viewed as a feasible therapeutic target for anti-allergic drug discovery. However, the effect of the methanolic extract of A. tenuissima and its constituents on histamine release have not been previously reported. As part of our on-going study to discover antiallergic natural products, we found that the MeOH extract of the roots of A. tenuissima suppressed the gene expressions of IL-6 and TNF-α.
Among the tested fractions (MeOH, MC, EtOAc, and water), the EtOAc fraction most potently inhibited the expressions of TNF-α and IL-6. Repetitive chromatography of the EtOAc fraction led to Results in terms of mean ± standard deviation. *Significant difference from phorbol 12-myristate 13-acetate (PMA) and A23187-activated group at P < 0.05.
Figure 1:
Anti-allergic inflammatory effects of compounds 1-7 isolated from A. tenuissima on human mast cells. HMC-1 cells were pre-incubated with compounds for 30 min prior to incubation with PMA (20 nM) and calcium ionophore A23187 (1 μM). Effect of compounds 1-7 shown on the expression of pro-inflammatory cytokines. Extraction and analysis of mRNA was performed as described in Experimental section.
the isolation of a phthalide (1), and six coumarins (2-7), which were identified as levistolide A (1) [2a] , demethylsuberosin (2), fraxetin
, and isopraeroside IV (7) [2f] using a combination of spectroscopic methods.
Compounds 1-7 were evaluated for their inhibitory potencies on histamine release at 10 µM. contributes to the inhibitory activities on histamine release. Moreover, compounds 1-3 and 5-7 inhibited the gene expression of IL-6. In particular, compounds 3 and 7 showed moderate suppressive activities to TNF-α by human mast cells. Based on these results, we suggest that levistolide A (a phthalide) and the six coumarins at least contribute to the anti-allergic inflammatory effect of the methanolic extract of the roots of A. tenuissima. Moreover, they could be valuable lead compounds for anti-allergic drug discovery. Further chemical investigations and biological evaluations are required to elucidate structure-activity relationships.
Experimental
Plant material: The roots of A. tenuissima were purchased from Yak-Ryung-Si Market in Daegu (Korea) and identified by Dr Seung Ho Lee, Yeungnam University. A voucher specimen (YU00192) has been deposited in the Natural Product Laboratory at the College of Pharmacy, Yeungnam University.
Extraction and isolation:
A dried sample (8.7 kg) was extracted with MeOH (25 L × 3) at room temperature, and the MeOH extract (1.8 kg) was obtained in vacuo. The extract was then suspended in water and extracted sequentially with MC, EtOAc, and BuOH, and fractions were concentrated to give the extracts of MC (334.1 g), EtOAc (24.5 g), BuOH (34.7 g), and water (1.3 kg). The EtOAcsoluble extract (24.5 g) was subjected to silica gel vacuum liquid chromatography and eluted with a MC/acetone gradient (from 100% MC to 100% acetone) to afford 10 fractions (ATET1-ATET10). ATET2 (18.2 g) was further chromatographed through a silica gel open column eluted with a hexanes/MC gradient (10:0 to 0:10) and provided 13 sub-fractions (ATET2A-ATET2M). ATET2F (1.6 g) was purified by preparative HPLC (20×250 mm, Shim-Pack Prep-ODS, flow rate 6 mL/min) using a MeOH: H 2 O linear gradient (from 70:30 to 100:0, 80 min) to yield compound 1 (58 mg, 55 min). Compounds 2 (88 mg, 29 min) and 3 (57 mg, 37 min) were isolated from ATET4 (1.9 g) by preparative HPLC (20×250 mm, Shim-Pack Prep-ODS, flow rate 6 mL/min) using an acetonitrile/H 2 O gradient (from 30:70 to 60:40, 60 min). The BuOH soluble fraction (34.7 g) was subjected to MCI gel (CHP-20P) using a stepwise gradient of H 2 O and MeOH (10:0 to 2:8) and the eluate was separated into 5 sub-fractions (ATW1-ATW5). ATW5 (1.7 g) was further fractionated by preparative HPLC (20×250 mm, ShimPack Prep-ODS, flow rate 6 mL/min) by isocratic elution (acetonitrile/H 2 O, 20:80) to afford compounds 4 (104 mg, 40 min), 5 (147 mg, 50 min), 6 (68 mg, 53 min), and 7 (87 mg, 56 min).
RNA extraction and semi-quantitative reverse transcription polymerase chain reaction: Total cellular RNA was isolated from the mast cells (1×10 6 /well in 24-well plates) stimulated with PMA (20 nM) and A23187 (1 μM) for 2 h using RNAiso Plus reagent (Takarabio Inc., Shiga, Japan), according to the manufacturer's protocol, and then incubated with compounds 1-7 for 30 min. cDNA was synthesized from 2 μg of total RNA using the Maxime RT-Pre Mix Kit (iNtRON Biotechnology, Daejeon, Korea). RT-PCR was used to determine the relative mRNA expressions of TNF-α, IL-6, and β-actin (internal control) using the Maxime PCR-Pre Mix kit (iNtRON Biotechnology). Primers were obtained from Genotech (Daejeon, Korea) and the conditions used for reverse transcription and PCR were as previously described [3] .
Histamine assay: Amounts of histamine released from mast cells were measured using an o-phthaldialdehyde spectrofluorometric procedure as previously described [3] .
Statistical analysis:
Results are the means and standard errors (SEs) of 3 independent experiments. The analysis was performed using Prism5 (GraphPad Software, San Diego, CA), and effects of treatments were analyzed using one-way ANOVA followed by Dunnett's test. P<0.05 was used to indicate significant differences throughout the study.
